Several distinct properties of the IgE repertoire determine effector cell degranulation in response to allergen challenge

Department of Experimental Immunology, ALK-Abelló A/S, Hørsholm, Denmark.
The Journal of allergy and clinical immunology (Impact Factor: 12.05). 07/2008; 122(2):298-304. DOI: 10.1016/j.jaci.2008.05.026
Source: PubMed

ABSTRACT On cross-linking of receptor-bound IgE antibodies by allergens, effector cells (basophils and mast cells) involved in type I allergic reactions degranulate and release the potent chemical mediators stored inside their granules. Total and allergen-specific IgE concentrations, IgE affinity for allergen, and IgE clonality are all distinct properties of allergic patients' IgE repertoires. However, the inability to isolate individual IgE antibodies from allergic patients' sera presents a major barrier to understanding the importance of patient-specific IgE repertoires for the manifestation and severity of allergic symptoms.
We sought to investigate how individual properties of an IgE repertoire affect effector cell degranulation.
A panel of recombinant IgE (rIgE) antibodies specific for the major house dust mite allergen Der p 2 was developed and characterized in regard to Der p 2 affinity, as well as Der p 2 epitope specificity, by using surface plasmon resonance technology. Human basophils were sensitized with different combinations of rIgEs, and degranulation responses were measured by means of flow cytometry after challenge with Der p 2.
A total of 31 Der p 2-specific rIgEs were produced. They bound a total of 9 different Der p 2 epitopes in the affinity range (K(D) value) of 0.0358 to 291 nM. Factors increasing human basophil degranulation were increased total IgE concentrations, increased concentrations of allergen-specific IgE relative to non-allergen-specific IgE, more even concentration of individual allergen-specific IgE clones, increased IgE affinity for allergen, and increased number of allergen epitopes recognized by the IgE repertoire (increased IgE clonality).
This study demonstrates how distinct properties of the IgE repertoire, such as total and allergen-specific IgE antibody concentration, IgE affinity, and IgE clonality, affect effector cell degranulation.

  • [Show abstract] [Hide abstract]
    ABSTRACT: The physiologic function of the "odd" Ab IgG4 remains enigmatic. IgG4 mediates immunotolerance, as, for example, during specific immunotherapy of allergies, but it mediates tissue damage in autoimmune pemphigus vulgaris and "IgG4-related disease." Approximately half of the circulating IgG4 molecules are bispecific owing to their unique ability to exchange half-molecules. Better understanding of the interrelation between IgG4 and IgE repertoires may yield insight into the pathogenesis of allergies and into potential novel therapies that modulate IgG4 responses. We aimed to compare the selective forces that forge the IgG4 and IgE repertoires in allergic asthma. Using an IgG4-specific RT-PCR, we amplified, cloned, and sequenced IgG4 H chain transcripts of PBMCs from 10 children with allergic asthma. We obtained 558 functional IgG4 sequences, of which 286 were unique. Compared with previously published unique IgE transcripts from the same blood samples, the somatic mutation rate was significantly enhanced in IgG4 transcripts (62 versus 83%; p < 0.001), whereas fewer IgG4 sequences displayed statistical evidence of Ag-driven selection (p < 0.001). On average, the hypervariable CDRH3 region was four nucleotides shorter in IgG4 than in IgE transcripts (p < 0.001). IgG4 transcripts in the circulation of children with allergic asthma reflect some characteristics of classical Ag-driven B2 immune responses but display less indication of Ag selection than do IgE transcripts. Although allergen-specific IgG4 can block IgE-mediated allergen presentation and degranulation of mast cells, key factors that influence the Ag-binding properties of the Ab differ between the overall repertoires of circulating IgG4- and IgE-expressing cells.
    The Journal of Immunology 11/2014; 193(12):5801-8. DOI:10.4049/jimmunol.1401409 · 5.36 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Background Group 5 allergens are small proteins that consist of two domains. They belong to the most potent respiratory allergens.Objective To determine the binding sites and to study allergic patients’ IgE recognition of the group 5 allergen (Phl p 5) from timothy grass pollen using human monoclonal IgE antibodies that have been isolated from grass pollen allergic patients.Methods Using recombinant isoallergens, fragments, mutants and synthetic peptides of Phl p 5, as well as peptide-specific antibodies, the interaction of recombinant human monoclonal IgE and Phl p 5 was studied using direct binding and blocking assays. Cross-reactivity of monoclonal IgE with group 5 allergens in several grasses was studied and inhibition experiments with patients’ polyclonal IgE were performed.ResultsMonoclonal human IgE showed extensive cross-reactivity with group 5 allergens in several grasses. Despite its small size of 29 kDa, four independent epitope clusters on isoallergen Phl p 5.0101, two in each domain, were recognized by human IgE. Isoallergen Phl p 5.0201 carried two of these epitopes. Inhibition studies with allergic patients’ polyclonal IgE suggest the presence of additional IgE epitopes on Phl p 5.Conclusions & Clinical RelevanceOur results reveal the presence of a large number of independent IgE epitopes on the Phl p 5 allergen explaining the high allergenic activity of this protein and its ability to induce severe allergic symptoms. High density IgE recognition may be a general feature of many potent allergens and form a basis for the development of improved diagnostic and therapeutic procedures in allergic disease.This article is protected by copyright. All rights reserved.
    Clinical & Experimental Allergy 09/2014; 44(11). DOI:10.1111/cea.12423 · 4.32 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: There are drawbacks for the decision tree strategies recommended by the Food and Agriculture Organization (FAO) and the World Health Organization (WHO) (FAO/WHO, 2001) in allergenicity assessment. In this study, we evaluated the allergenic activity of glycinin (Gly), ovalbumin (OVA) and potato acid phosphatase (PAP) by using an RBL cell-based immunological assay and the decision tree strategies. We then further analyzed the complementary applications between the RBL cell-based immunological assay and the decision tree strategies. A bioinformatical analysis predicted that the ranking of potential allergenicity was Gly > OVA > PAP, which was determined by analyzing the linear-epitope regions. However, the RBL cell-based immunological assay can determine the ability of the linear and conformational epitopes to induce allergic reactions. A pepsin digestion assay indicated that Gly was more stable compared with OVA and that PAP had no stability in simulated gastric fluid. However, this approach cannot fully reflect the results of food proteins digested in the gastrointestinal tract. Anaphylactic reactions in Balb/c mice and optimal beta-hexosaminidase release of RBL-2H3 cells were induced with Gly followed by OVA; no significant response and < 10% release were obtained with PAP. Compared with the animal models, the RBL cell-based immunological assay is more suitable for evaluating the allergenic activity of food proteins based on the simple characteristics of the testing system. The RBL cell-based immunological assay may play a "referee" role when inconsistent results between a bioinformatical analysis and a pepsin digestion assay occur, and animal models may be used to further dissect the mechanisms of the allergic responses. Thus complementary applications between the RBL cell-based immunological assay and the decision tree strategies will be a good choice to conduct a complete evaluation of the allergenic potential of foods.
    Food Research International 08/2014; 62:735-745. DOI:10.1016/j.foodres.2014.04.033 · 3.05 Impact Factor

Full-text (2 Sources)

Available from
Aug 4, 2014